Healthcare -
Drug Manufacturers - General - NYSE - DK
$ 74.79
-4.25 %
$ 328 B
Market Cap
22.66
P/E
NVO - NET INCOME
Net Income NVO - Novo Nordisk A/S
101 B
LAST VALUE
34.86%
2 YEAR CAGR
20.99%
5 YEAR CAGR
14.32%
10 YEAR CAGR